Article
Full Access
Review of myo-inositol and sorbinil studies
R.S. Clements Jr.,
R.S. Clements Jr.
University of Alabama at Birmingham and Veterans Administration Medical Center Birmingham, Alabama, USA
Search for more papers by this authorR.S. Clements Jr.,
R.S. Clements Jr.
University of Alabama at Birmingham and Veterans Administration Medical Center Birmingham, Alabama, USA
Search for more papers by this author
References
- Clements R.S., Vorganti B., et al. (1979) Dietary myo-inositol intake and peripheral nerve function in diabetic neuropathy. Metabolism, 28 (Suppl. 1), 477.
- Culebras A., Alio K. et al. (1981) Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Arch Neurol, 38, 133.
- Fagius J. & Jameson S. (1981) Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study. J Neurol Neurosurg Psychiat 44, 991.
- Greene D.A., de Jesus P.V., Jr. & Winegrad A.I. (1975) Effects of insulin and dietary myo-inositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin-diabetes. J Clin Invest 55, 1326.
- Greene D.A., Brown M.J., et al. (1981) Comparison of clinical course and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes 30, 139.
- Greene D.A. & Lattimer S.A. (1982) Sodium-and energy-dependent uptake of myoinositol by rabbit peripheral nerve: competitive inhibition by glucose and lack of an insulin effect. J Clin Invest, 70, 1009.
- Greene D.A. and Lattimer S.A. (1984) Action of sorbinil in diabetic peripheral nerves: relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes, 33, 712.
- Gregersen G., Borsting H et al. (1978) Myo-inositol and function of peripheral nerves in human diabetics. Acta Neurol Scand 58, 241.
- Handlesman D.J. & Turtle J.R. (1981) Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes 30, 459.
- Jaspan J., Herold K. et al. (1983) Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved sonatic and autonomic nerve function. Lancet, II, 758.
- Judzewitsch R.G., Jaspan J.B. et al. (1983) Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. New Engl J Med, 308, 119.
- Mayer J.H. & Tomlinson D.R. (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia, 25, 433.
- Palmano K.P., Whiting P.H. & Hawthorne J.N. (1977) Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. Biochem J, 167, 229.
- Pietri A., Ehle A.L. & Raskin P. (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes, 29, 669.
- Tomlinson D.R., Holmes P.R. & Mayer J.H. (1982) Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes. Neurosci Lett, 31, 189.
- Ward J.D., Barnes C.G., Fischer D.J., Jessop J.D. & Baker RWR (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet I, 428.
10.1016/S0140-6736(71)92415-9 Google Scholar
- Young R.J., Ewing D.J. & Clarke B.G. (1983) A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 32, 938.
